Skip to main content

Roundup's Primary Glyphosate Safe To Use Assures EPA

Roundup's Primary Glyphosate Safe To Use Assures EPA

Roundup's Primary Glyphosate Safe To Use Assures EPA

Introduction

EPA recently announced over the usage of Glyphosate that it doesn't cause cancer.

According to the review, glyphosate is the most-used herbicide in the U.S and meets the standard in the Federal Insecticide, Fungicide, and Rodenticide Act. It is one of the primary ingredients of Roundup. The California Office of Environmental Health Hazard Assessment had included glyphosate on a list of carcinogenic chemicals based on the World Health Organization’s  International Agency for Research(IARC). EPA stated, it probably doesn't cause cancer and can be used with some fine adjustments; also, its testing methods are more superior than IARC's.

The first trial against Monsanto over Roundup was held last summer in state court in San Francisco, which ruled in favor of plaintiffs with $78 million. The second ended last month in federal court with an $80 million verdict, including $75 million in punitive damages. The third trial is ongoing.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.